These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30640943)

  • 1. Chemotherapeutic agent 5-fluorouracil increases survival of SOD1 mouse model of ALS.
    Rando A; de la Torre M; Martinez-Muriana A; Zaragoza P; Musaro A; Hernández S; Navarro X; Toivonen JM; Osta R
    PLoS One; 2019; 14(1):e0210752. PubMed ID: 30640943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
    Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
    Cervetto C; Frattaroli D; Maura G; Marcoli M
    Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis.
    Ahn SW; Jeon GS; Kim MJ; Shon JH; Kim JE; Shin JY; Kim SM; Kim SH; Ye IH; Lee KW; Hong YH; Sung JJ
    J Neurol Sci; 2014 May; 340(1-2):112-6. PubMed ID: 24680562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.
    Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN
    J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mouse model with impaired dynein/dynactin function develops amyotrophic lateral sclerosis (ALS)-like features in motor neurons and improves lifespan in SOD1-ALS mice.
    Teuling E; van Dis V; Wulf PS; Haasdijk ED; Akhmanova A; Hoogenraad CC; Jaarsma D
    Hum Mol Genet; 2008 Sep; 17(18):2849-62. PubMed ID: 18579581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An oligomer-specific antibody improved motor function and attenuated neuropathology in the SOD1-G93A transgenic mouse model of ALS.
    Dong QX; Zhu J; Liu SY; Yu XL; Liu RT
    Int Immunopharmacol; 2018 Dec; 65():413-421. PubMed ID: 30388515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autophagy activation and neuroprotection by progesterone in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis.
    Kim J; Kim TY; Cho KS; Kim HN; Koh JY
    Neurobiol Dis; 2013 Nov; 59():80-5. PubMed ID: 23891729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple administrations of human marrow stromal cells through cerebrospinal fluid prolong survival in a transgenic mouse model of amyotrophic lateral sclerosis.
    Zhang C; Zhou C; Teng JJ; Zhao RL; Song YQ; Zhang C
    Cytotherapy; 2009; 11(3):299-306. PubMed ID: 19333801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CNS-targeted glucocorticoid reduces pathology in mouse model of amyotrophic lateral sclerosis.
    Evans MC; Gaillard PJ; de Boer M; Appeldoorn C; Dorland R; Sibson NR; Turner MR; Anthony DC; Stolp HB
    Acta Neuropathol Commun; 2014 Jun; 2():66. PubMed ID: 24923195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective Effect of Human Adipose Stem Cell-Derived Extract in Amyotrophic Lateral Sclerosis.
    Jeon GS; Im W; Shim YM; Lee M; Kim MJ; Hong YH; Seong SY; Kim M; Sung JJ
    Neurochem Res; 2016 Apr; 41(4):913-23. PubMed ID: 26646002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuregulin 1 confers neuroprotection in SOD1-linked amyotrophic lateral sclerosis mice via restoration of C-boutons of spinal motor neurons.
    Lasiene J; Komine O; Fujimori-Tonou N; Powers B; Endo F; Watanabe S; Shijie J; Ravits J; Horner P; Misawa H; Yamanaka K
    Acta Neuropathol Commun; 2016 Feb; 4():15. PubMed ID: 26891847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of adenosine 2a receptor (A2aR)-mediated adenosine signaling improves disease phenotypes in a mouse model of amyotrophic lateral sclerosis.
    Ng SK; Higashimori H; Tolman M; Yang Y
    Exp Neurol; 2015 May; 267():115-22. PubMed ID: 25779930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human erythropoietin suppresses symptom onset and progression of G93A-SOD1 mouse model of ALS by preventing motor neuron death and inflammation.
    Koh SH; Kim Y; Kim HY; Cho GW; Kim KS; Kim SH
    Eur J Neurosci; 2007 Apr; 25(7):1923-30. PubMed ID: 17439481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neuroprotective effect of the GSK-3β inhibitor and influence on the extrinsic apoptosis in the ALS transgenic mice.
    Ahn SW; Kim JE; Park KS; Choi WJ; Hong YH; Kim SM; Kim SH; Lee KW; Sung JJ
    J Neurol Sci; 2012 Sep; 320(1-2):1-5. PubMed ID: 22698482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
    Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
    Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 Deficiency Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutation.
    Han Y; Ripley B; Serada S; Naka T; Fujimoto M
    PLoS One; 2016; 11(4):e0153399. PubMed ID: 27070121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal delivery of insulin and a nitric oxide synthase inhibitor in an experimental model of amyotrophic lateral sclerosis.
    Martinez JA; Francis GJ; Liu WQ; Pradzinsky N; Fine J; Wilson M; Hanson LR; Frey WH; Zochodne D; Gordon T; Toth C
    Neuroscience; 2008 Dec; 157(4):908-25. PubMed ID: 18951954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colivelin prolongs survival of an ALS model mouse.
    Chiba T; Yamada M; Sasabe J; Terashita K; Aiso S; Matsuoka M; Nishimoto I
    Biochem Biophys Res Commun; 2006 May; 343(3):793-8. PubMed ID: 16564029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression.
    Apolloni S; Fabbrizio P; Amadio S; Volonté C
    J Neuroinflammation; 2016 Aug; 13(1):191. PubMed ID: 27549088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.